Part 5: How to Actually Protect a Medical-AI Web App in the Cloud Era (Series Finale) [Paid]
"If we patent it, can't a competitor just move their servers offshore and walk away?" It's the single most common fear we hear from teams building cloud-based medical-AI web apps.
In the opening installment of this series we posed a simple question: how do you actually protect software like this? In 2025, a landmark Japanese Supreme Court ruling quietly—but decisively—changed the premise behind the answer. Do you really need to file everywhere on Earth? What does protection cost per country? And how do you anticipate, at filing time, the workarounds that follow-on competitors inevitably attempt? This finale lays out real cost figures, concrete claim-drafting tactics for medical AI, and a three-layer defense combining patents, trade secrets, and contracts.
Read the full article
This is a premium article. A membership ($10/mo) unlocks every article (plus the full-series PDF once a series is complete), or buy just this one for $2 (48 hours), or the whole series for $7 (60 days; the full-series PDF is downloadable once all parts are published).
Please log in or sign up to subscribe or buy.
Log in / Sign up →
![Part 2: Can a Server Abroad Still Escape a Patent? Inside the Landmark Dwango v. FC2 Ruling [Paid]](/static/images/blog/fig/fig-medai-web-patent-strategy-2-cross-border-data-hero.png)
![Part 3: Does a Patent Really 'Reach' a Medical AI Service? The Architecture That Decides [Paid]](/static/images/blog/fig/fig-medai-web-patent-strategy-3-p3-hero.png)
![Part 4: When Your Customer Is Anyone — or an AI — Anywhere: API Access and the Vanishing 'Infringer' [Paid]](/static/images/blog/fig/fig-medai-web-patent-strategy-4-p4-hero.png)
![Part 5: How to Actually Protect a Medical-AI Web App in the Cloud Era (Series Finale) [Paid]](/static/images/blog/fig/fig-medai-web-patent-strategy-5-p5-hero.png)
![Part 3: How a University-Held 'Foundational Patent' Generated Fortunes — Two Legendary Patents That Succeeded for Opposite Reasons [Paid]](/static/images/blog/fig/fig-univ-medai-ip-cases-3-university-basic-patent-two-strategies.png)
![Part 2: When a Nobel-Winning Discovery Ended Up in Court — The University–Pharma Royalty Trap [Paid]](/static/images/blog/fig/fig-univ-medai-ip-cases-2-discovery-to-courtroom.png)
